Clinical trial
Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian…
NCT00052468 · AGO Study Group, Other · Completed
Key facts
| NCT number | NCT00052468 |
|---|---|
| Title | Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer |
| Official title | A Multi-National Randomized Phase-III GCIG Intergroup-Study Comparing 1st-line Chemotherapy With Gemcitabine/Paclitaxel/Carboplatin vs Paclitaxel/Carboplatin In Previously Untreated Patients With Epithelial Ovarian Cancer FIGO Stages I-IV |
| Acronym | AGO-OVAR9 |
| Lead sponsor | AGO Study Group, Other |
| Collaborators | Nordic Society of Gynaecological Oncology - Clinical Trials Unit GERCOR - Multidisciplinary Oncology Cooperative Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer |
| Intervention type | Drug |
| Interventions | TCG, TC |
| Enrollment | 1,742 |
| Start date | Aug 1, 2002 |
| Primary completion | Jul 1, 2009 |
| Completion | Jan 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 25, 2014 |
| Countries | Denmark, France, Germany, Norway |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: